<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">Also, the last version (7th edition) of the Guidelines for the Prevention, Diagnosis, and Treatment of Novel Coronavirus-induced Pneumonia [
 <xref ref-type="bibr" rid="CR14">14</xref>] included as useful therapy, together with the antimalarial chloroquine and the antiviral treatment for influenza arbidol, the broad-spectrum antiviral agent Ribavirin, a guanosine analogue used to treat several virus infections like hepatitis C virus, respiratory syncytial virus and viral hemorrhagic fevers. However, for its undesiderable side effect like anemia, the use of ribavirin may not be convenient in patients who are already very compromised such as those with COVID-19 [
 <xref ref-type="bibr" rid="CR13">13</xref>â€“
 <xref ref-type="bibr" rid="CR15">15</xref>].
</p>
